Published online Feb 7, 2015. doi: 10.3748/wjg.v21.i5.1371
Peer-review started: September 30, 2014
First decision: October 29, 2014
Revised: November 6, 2014
Accepted: January 8, 2015
Article in press: January 8, 2015
Published online: February 7, 2015
Processing time: 133 Days and 5.1 Hours
Screening for colorectal cancer (CRC) has been associated with a decreased incidence and mortality from CRC. However, patient adherence to screening is less than desirable and resources are limited even in developed countries. Better identification of individuals at a higher risk could result in improved screening efforts. Over the past few years, formulas have been developed to predict the likelihood of developing advanced colonic neoplasia in susceptible individuals but have yet to be utilized in mass screening practices. These models use a number of clinical factors that have been associated with colonic neoplasia including the body mass index (BMI). Advances in our understanding of the mechanisms by which obesity contributes to colonic neoplasia as well as clinical studies on this subject have proven the association between BMI and colonic neoplasia. However, there are still controversies on this subject as some studies have arrived at different conclusions on the influence of BMI by gender. Future studies should aim at resolving these discrepancies in order to improve the efficiency of screening strategies.
Core tip: Colorectal cancer has been associated with various risk factors like gender, race, smoking, obesity, diet, but these have not been utilized to refine our screening practices. The available evidence, the suggested role of inflammatory markers and the practical ease of use suggests that incorporation of body mass index accounting for gender and age differences can be used to supplement risk calculators for predicting the occurrence of colorectal adenomas and hence fine tune our screening practices.